ripekg:evaluation/RIPEACF96EE4CD6A96F4B |
prov:wasInformedBy |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |
rdf:type |
rdfs:Resource |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |
rdf:type |
owl:Thing |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |
rdf:type |
ripe:EvidenceAggregationEvidence aggregation |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |
rdf:type |
tido:Activity |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |
prov:startedAtTime |
2025-10-31T14:52:26.181663Z |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |
prov:wasAssociatedWith |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |
tido:contributesTo |
ripekg:research-integrity-assessment/RIPEACF96EE4CD6A96F4B |
ripekg:publication-details/RIPEACF96EE4CD6A96F4BEffect of saffron supplementation on Parkinson’s disease: a study protocol for a triple-blind randomised controlled clinical trial |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |
ripekg:registry-evidence/RIPEACF96EE4CD6A96F4B |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |
ripekg:retraction-notice/28473Clinical trial of the effects of coenzyme Q10 supplementation on glycemic control and markers of lipid profiles in diabetic hemodialysis patients |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |
ripekg:study-design-evidence/RIPEACF96EE4CD6A96F4B |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEACF96EE4CD6A96F4B |